793
Participants
Start Date
March 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Naltrexone SR 32 mg/ bupropion SR 360 mg/ day
Placebo
Intensive group lifestyle modification counseling
New York Obesity Research Center, St. Luke's-Roosevelt Hospital Center, New York
Center for Weight and Eating Disorders, School of Med., University of Penn., Philadelphia
Center for Obesity Research and Education, Temple University, Philadelphia
Medical University of S. Carolina Weight Management Center, Charleston
Univ. of Florida, College of Public Health, and Health Professions, Gainesville
Washington Univ. Center for Human Nutrition, St Louis
Behavioral Medicine Research Center, Houston
Center for Human Nutrition, University of Colorado Health Services Center, Denver
University of California, San Diego: Dept of Family & Preventive Medicine, La Jolla
Lead Sponsor
Orexigen Therapeutics, Inc
INDUSTRY